The impact of pricing policies on ongoing clinical trials

Trump's completely erratic economic policy is sabotaging any hope of short-term gains in the area we're concerned with. I no longer believe in the RJK effect of certain deregulations or purges within the FDA. The only thing that can help us in the medium or long term is the success of Compass and other players in the field in their Phase 3.